Author Archives: blogger

Clinical Trials of Buteyko Respiration Technique for Asthma

Breathing techniques and respiration devices become more and more popular among asthmatics and people with other respiratory problems. Among the known breathing techniques is the Buteyko breathing method, which had six randomised controlled trials in western countries.

The results were remarkable: twice less steroids, 3-10 times less reliever medication, better quality of life and less asthma symptoms, but unchanged bronchial responsiveness or lung function results after several months of breathing exercises. Meanwhile, all these studies had a major methodological flaw, which I am going to consider here.

Dr. K. Buteyko made the following clinical statements:
– Sick people, asthmatics including, breathe more air at rest than the minuscule medical norm (chronic hyperventilation). Overbreathing reduces tissue oxygenation and strengthens the desire to breathe even more.
– If they normalize their breathing pattern, then they will not require medication and will not experience their symptoms.
– The Buteyko Table of Health Zones relates breathing parameters of sick people, regardless of the name of the disease, with their current health state. This table describes parameters that reflect normal breathing (8 breaths/min for breathing frequency at rest, 6.5 percent for alveolar CO2 content, 60 seconds for stress-free breath holding time after usual exhalation, etc.). These parameters correspond to normal health and absence of asthma and many other chronic diseases since normal breathing improves body oxygenation.
– Someone has mastered the Buteyko breathing method, if his breathing parameters are normal.

Dr KP Buteyko never made claims that a particular Buteyko practitioner could achieve a particular result in relation to some group of asthmatics. Let us apply these Buteykos claims to available scientific data and the results of these randomised controlled trials.

First of all, hundreds of scientific research publications have shown that hyperventilation DIMINISHES oxygen content in body tissues.

Do asthmatics breathe much more air than the medical norm? A typical respiratory minute ventilation for an average asthmatic is about 12-15 L of air in one minute at rest (5 publications are available on my website), while the medical norm is only 6 L/min. Therefore, asthmatics breathe at rest about 2-2.5 times more air than the physiological standard.

Did asthmatics improve their breath parameters during these randomised controlled trials of the Buteyko breathing method? During the most impressive study (Bowler et al, 1998), in 3 months, use of relievers was reduced by 96 percent (25 times less ventolin) and preventers or inhaled steroids by 50%. Respiratory minute volume decreased from their initial 14 L/min to 9.6 L/min, but the physiological norm is only 6 L/min, while Dr. Buteykos hard standard is 4 L/min at rest for a 70-kg man. Hence, during their best shot, the participated asthmatics got only about a half way towards the standard. Consequently, there were a very few asthmatics, if any, who normalized their breath during these trials. They continued to hyperventilate.

The assumption of the medical doctors, who conducted these randomised controlled trials, was that a Buteyko teacher taught the Buteyko breathing method and a controlled group “learned” the method. This is easy to see from the titles, which usually say about a “trial of the Buteyko method”. How could they study the method, if no one learned it?

From a practical view, since I taught the Buteyko method to hundreds of people, the key difficulty during these randomised controlled trials were the following. The participants were mainly limited to practicing breathing exercises (e.g., 40-70 min per day). They could not use the versatile arsenal of life-style addressing tools of the Buteyko method. Breathing normalization process requires 24/7 control of breathing including:
– nasal breathing all the time (hence, it is necessary then to seal ones mouth with a surgical tape, if the mouth is usually dry in the morning; and someone will never solve their problems with asthma, if mouth breathing occurs during each night
– physical exercise (no less than 2 hours daily with only nasal breathing, in and out, otherwise exercise is more or less ineffective for most, especially sick people)
– prevention of sleeping on ones back (we breathe about two times more air, when we sleep on our backs at night)
– and various other lifestyle-related factors so that ones basal breathing pattern is restored back to our physiological standard.

Even more successful results have been discovered after application of the Frolov Breathing Device during recent clinical trails in Russia (under review and to be published in 2011).

Acute Respiratory Distress Syndrome Information

Respiratory distress syndrome (RDS) is a breathing problem. It is lung disorder that commonly affects premature infants. Sometimes affects babies born about 6 weeks or more before their due dates. RDS affected an mostly infants born alive in the United States. Acute respiratory distress syndrome (ARDS) is the rapid onset of respiratory failure (ability to adequately oxygenate the blood) that can occur in critically ill persons of any age over 1 year. This is the most important disorder resulting in increased permeability pulmonary edema. It is characterized by inflammation of the lung parenchyma leading to impaired gas exchange with concomitant systemic release of inflammatory mediators causing inflammation, hypoxemia and frequently resulting in multiple organ failure.

ARDS has a death rate of approximately 30 to 40 percent. The estimated annual frequency of ARDS is reported as 75 cases per 100,000 population. ARDS Symptoms include severe difficulty in breathing , anxiety, agitation and fever. ARDS infants may develop several complications such as sepsis, an infection of the bloodstream, as well as other problems related to prematurity, such as bleeding into the brain. These and other complications can cause convulsions, shock-like states, and in some cases, death. ARDS patients are usually treated in the intensive. Treatment is primarily supportive using a mechanical respirator and supplemental oxygen. A supportive breathing technique called positive end expiratory pressure. These are combined with continuing treatment of the precipitating illness.

Corticosteroids may sometimes be administered in late phases of ARDS or if the patient is in shock. Intravenous fluids are given to provide nutrition and prevent dehydration. Antianxiety drugs to relieve anxiety. Drugs to counteract low blood pressure that may be caused by shock Inhaled nitric oxide (NO) potentially acts as selective pulmonary vasodilator. Rapid binding to hemoglobin prevents systemic effects. It should increase perfusion of better ventilated areas. A risk factor for ARDS, taking appropriate measures to prevent aspiration, such as elevation of the head of the bed, may prevent some cases of ARDS. There are many therapies such as, replacement surfactant (a natural soapy substance that keeps the lung air sacs open) may be beneficial.

Acute Respiratory Distress Syndrome Treatment and Prevention Tips

1. Intravenous fluids are given to provide nutrition.

2. Use of a surfactant preparation can be lifesaving and reduces complications.

3. Corticosteroids have been used empirically and in numerous clinical trials.

4. Replacement surfactant therapy may be beneficial.

5. Rapid binding to hemoglobin prevents systemic effects.

6. Antianxiety drugs to relieve anxiety.